Cargando…

Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses’ Vaccinated Solid Organ Transplant Recipients

Solid organ transplant recipients (SOTRs) show higher rates of COVID-19 breakthrough infection than the general population, and nowadays, vaccination is the key preventative strategy. Nonetheless, SOTRs show lower vaccine efficacy for the prevention of severe COVID-19. Moreover, the emergence of new...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busà, Rosalia, Russelli, Giovanna, Miele, Monica, Sorrentino, Maria Concetta, Di Bella, Mariangela, Timoneri, Francesca, Di Mento, Giuseppina, Mularoni, Alessandra, Vitulo, Patrizio, Conaldi, Pier Giulio, Bulati, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611839/ https://www.ncbi.nlm.nih.gov/pubmed/36298854 http://dx.doi.org/10.3390/v14102299

Ejemplares similares

Analysis of the Specific Immune Response after the Third Dose of mRNA COVID-19 Vaccines in Organ Transplant Recipients: Possible Spike-S1 Reactive IgA Signature in Protection from SARS-CoV-2 Infection
por: Miele, Monica, et al.
Publicado: (2022)

Impaired anti-SARS-CoV-2 humoral and cellular immune response induced by Pfizer-BioNTech BNT162b2 mRNA vaccine in solid organ transplanted patients
por: Miele, Monica, et al.
Publicado: (2021)

Specific Anti-SARS-CoV-2 Humoral and Cellular Immune Responses After Booster Dose of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine: Integrated Study of Adaptive Immune System Components
por: Busà, Rosalia, et al.
Publicado: (2022)

Long-Term Effectiveness of BNT162b2 Pfizer-BioNTech mRNA-Based Vaccine on B Cell Compartment: Efficient Recall of SARS-CoV-2-Specific Memory B Cells
por: Busà, Rosalia, et al.
Publicado: (2022)

Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment
por: Chinnici, Cinzia Maria, et al.
Publicado: (2021)

Complete intra-laboratory validation of a LAL assay for bacterial endotoxin determination in EBV-specific cytotoxic T lymphocytes
por: Pasqua, Salvatore, et al.
Publicado: (2021)

Complete intra-laboratory validation of a LAL assay for bacterial endotoxin determination in EBV-specific cytotoxic T lymphocytes
por: Pasqua, Salvatore, et al.
Publicado: (2021)

Proof-of-Concept Analysis of B Cell Receptor Repertoire in COVID-19 Patients Undergoing ECMO by Single-Cell V(D)J and Gene Expression Sequencing
por: Gallo, Alessia, et al.
Publicado: (2023)

Successful Use of Heterologous CMV-Reactive T Lymphocyte to Treat Severe Refractory Cytomegalovirus (CMV) Infection in a Liver Transplanted Patient: Correlation of the Host Antiviral Immune Reconstitution with CMV Viral Load and CMV miRNome
por: Miele, Monica, et al.
Publicado: (2021)

Klebsiella pneumoniae Lipopolysaccharides Serotype O2afg Induce Poor Inflammatory Immune Responses Ex Vivo
por: Bulati, Matteo, et al.
Publicado: (2021)

Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives
por: Miceli, Vitale, et al.
Publicado: (2023)

Different priming strategies improve distinct therapeutic capabilities of mesenchymal stromal/stem cells: Potential implications for their clinical use
por: Miceli, Vitale, et al.
Publicado: (2023)

Computational design and characterization of a multiepitope vaccine against carbapenemase-producing Klebsiella pneumoniae strains, derived from antigens identified through reverse vaccinology
por: Cuscino, Nicola, et al.
Publicado: (2022)

Fourth dose of COVID-19 vaccines in Israel
por: Burki, Talha Khan
Publicado: (2022)

Hepatocellular carcinoma, hepatitis C virus infection and miRNA involvement: Perspectives for new therapeutic approaches
por: Badami, Ester, et al.
Publicado: (2022)

Tissue-Resident Innate Immune Cell-Based Therapy: A Cornerstone of Immunotherapy Strategies for Cancer Treatment
por: Busà, Rosalia, et al.
Publicado: (2022)

Human Amnion-Derived Mesenchymal Stromal/Stem Cells Pre-Conditioning Inhibits Inflammation and Apoptosis of Immune and Parenchymal Cells in an In Vitro Model of Liver Ischemia/Reperfusion
por: Zito, Giovanni, et al.
Publicado: (2022)

Two Sides of The Same Coin: Normal and Tumoral Stem Cells, The Relevance of In Vitro Models and Therapeutic Approaches: The Experience with Zika Virus in Nervous System Development and Glioblastoma Treatment
por: Tinnirello, Rosaria, et al.
Publicado: (2023)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection
por: Carreca, Anna Paola, et al.
Publicado: (2022)

Extracellular Vesicle-Derived microRNAs of Human Wharton’s Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis
por: Chinnici, Cinzia Maria, et al.
Publicado: (2021)

Duration of humoral response to the third dose of BNT162b2 vaccine in patients with solid cancer: Is fourth dose urgently needed?
por: Di Noia, Vincenzo, et al.
Publicado: (2022)

Improving childhood vaccination coverage rates: the case of fourth dose of DTaP
por: Clark, Sarah J., et al.
Publicado: (2020)

Risk Factors Associated with Children Missing the Fourth Dose of DTaP Vaccination
por: Zhao, Zhen
Publicado: (2015)

Fourth-dose boosters with COVID-19 mRNA vaccines well tolerated
Publicado: (2022)

Attitudes of Healthcare Workers in Israel towards the Fourth Dose of COVID-19 Vaccine
por: Ramot, Shira, et al.
Publicado: (2023)

Fourth dose of COVID-19 vaccine: Does it still contribute any additional immunoprotection?
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
por: Regev-Yochay, Gili, et al.
Publicado: (2022)

The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
por: Khong, Ka-Wa, et al.
Publicado: (2022)

The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors
por: Bulati, Matteo, et al.
Publicado: (2020)

SARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?
por: Stasi, Cristina, et al.
Publicado: (2022)

Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
por: Bladh, Oscar, et al.
Publicado: (2023)

Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients
por: Joo, Yoosun, et al.
Publicado: (2023)

A Fourth Dose of COVID-19 Vaccine Does Not Induce Neutralization of the Omicron Variant Among Solid Organ Transplant Recipients With Suboptimal Vaccine Response
por: Karaba, Andrew H., et al.
Publicado: (2022)

(347) Augmented Humoral Response to a Third And Fourth Dose of Mrna Sars-Cov-2 Vaccines in Lung Transplant Recipients
por: Kawana, S., et al.
Publicado: (2023)

Efficacy and safety of a fourth dose of the COVID-19 vaccine in kidney transplant recipients: A systematic review and meta-analysis
por: Kuniduzi, Yasen, et al.
Publicado: (2023)

Phaeohyphomycosis in Solid Organ Transplant Recipients: A Case Series and Narrative Review of the Literature
por: Lo Porto, Davide, et al.
Publicado: (2023)

Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study
por: Xu, Qiu-Yan, et al.
Publicado: (2022)

Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose
por: Canetti, Michal, et al.
Publicado: (2022)

Eight-Month Follow-up After the Third Dose of BNT162b2 Vaccine in Healthcare Workers: The Question of a Fourth Dose
por: Lim, Sung Hee, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_u9ttdr7m8m1tdtavtgs5j2j8r3